ABRILADA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 4f85d34d6e776f58
Drug Approval Canada Name: ABRILADA
Product Name: ABRILADA
Status: Marketed
Status Date: 2022-03-07
Original Market Date: 2022-03-07
Din: 02511053
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB04 ADALIMUMAB
Atc Name: l 04 ab 04
Aig Number: 0150364003
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

ADALIMUMAB

40 MG / 0.8 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

4f85d34d6e776f58

Type

Standard